Café

© 2026 Longbridge｜Terms of Service Privacy Policy

002907

002907

14.265.87%( -0.89 )

LongbridgeAI

Pharscin Pharma: Cang Er Zi Nasal Inflammation Capsules have completed domestic drug filing

Zhitong

Jul 7, 2025 at 04:38 AM

Pharscin Pharma announced that its product Cang'erzi Rhinitis Capsules has completed the domestic production drug filing

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Pharscin Pharma

002907.SZ

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--